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ABSTRACT: Endometriosis is a common incurable inflammatory disorder that is associated with debilitating pelvic
pain in women. Macrophages are central to the pathophysiology of endometriosis: they dictate the growth and
vascularizationofendometriosis lesionsandmore recentlyhavebeenshowntopromote lesion innervation.Theaim
of this study was to determine the mechanistic role of macrophages in producing pain associated with endome-
triosis. Herein, we show that macrophage depletion in a mouse model of endometriosis can reverse abnormal
changes in pain behavior. We identified that disease-modified macrophages exhibit increased expression of IGF-1
in an in vitro model of endometriosis-associated macrophages and confirmed expression by lesion-resident mac-
rophages in mice and women. Concentrations of IGF-1 were elevated in peritoneal fluid from women with endo-
metriosis andpositively correlatewith their pain scores.Mechanistically,wedemonstrate thatmacrophage-derived
IGF-1 promotes sprouting neurogenesis and nerve sensitization in vitro. Finally, we show that the Igf-1 receptor
inhibitor linsitinib reverses the pain behavior observed in mice with endometriosis. Our data support a role for
macrophage-derived IGF-1 as a key neurotrophic and sensitizing factor in endometriosis, and we propose that
therapies thatmodifymacrophagephenotypemaybeattractive therapeuticoptions for the treatmentofwomenwith
endometriosis-associated pain.—Forster, R., Sarginson, A., Velichkova, A., Hogg, C., Dorning, A., Horne, A. W.,
Saunders, P. T. K., Greaves, E. Macrophage-derived insulin-like growth factor-1 is a key neurotrophic and
nerve-sensitizing factor in pain associated with endometriosis. FASEB J. 33, 000–000 (2019). www.fasebj.org
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Endometriosis is a chronic incurable estrogen-dependent
inflammatory disorder affecting an estimated 176 million
women worldwide (1). It is associated with debilitating
chronic pelvic pain and infertility and can significantly
impair health-related quality of life (2–4). Endometriosis is
defined by the attachment and growth of endometrial-like
tissue outside the uterine cavity (endometriosis lesions),
and current treatment options are limited to surgical abla-
tion or excision of lesions or medical management to sup-
press ovarian hormone production. However, symptoms
recurwithin5yr in40–50%ofwomenfollowingsurgery (5),
and medical management often has unwanted side-effects
and is contraceptive (6). There is an unmet clinical need for
newmedical treatments for women with endometriosis.
Endometriosis lesions recruit sensory nerve fibers (7, 8)
that innervate the ectopic endometrial tissue and can be
activated by the local neuroinflammatory milieu (9). Re-
peated interactions between peripheral sensory afferents
(nociceptors) and cytokines and neurotrophins have been
shown in other chronic pain conditions to cause nerve sen-
sitization: an enhanced responsiveness of afferents (10),
leading to a resultant increase in excitability of the ner-
vous system and triggering pain hypersensitivity or allo-
dynia (11, 12). In a mouse model of endometriosis (13) that
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recapitulates changes in sensory behavior and mirrors the
range of painful manifestations observed in women with
endometriosis,wehavedemonstratedmolecularalterations
along the pain axis resulting from the presence of endome-
triosis lesions (14).
Monocytes and macrophages in tissues are known to
play active roles in pain by producing a range of pronoci-
ceptive molecules. These include cytokines, neurotrophins,
and prostaglandins that can activate nerves by binding to
their cognate receptors, triggering intracellular signaling
cascades that induce sensitization by activation or up-
regulation of nociceptive ion channels such as transient re-
ceptor potential cation channel (TRP) A1, TRPV1, and the
sodium ion channels Nav1.7–1.9 (10, 15, 16). The extent to
which signals from macrophages generate changes in sen-
sorybehavior isdependenton thecauseofpain;mechanical
hypersensitivity caused by sterile incision as a model of
tissue injury based inflammation is rescuedbymacrophage
depletion, whereas monocytes seemingly have no effect
(17). However, in a model of chemotherapy-induced neu-
ropathic pain, monocytes migrate into peripheral nerves
and produce reactive oxygen species that generate pain by
activating TRPA1 (18). In disease models of pain, macro-
phages play a key role. For example, in an osteoarthritis
model, C-C motif chemokine receptor 2 (Ccr2) signaling, a
key driver of macrophage recruitment, is required for
movement-provoked pain behaviors (19), and in mice
prone to lupus (systemic lupus erythematosus), blocking
macrophage colony stimulating factor (m-csf; a factor crit-
ical formacrophagerecruitmentandsurvival) canattenuate
thermal hyperalgesia (20). In ratswith diabetic neuropathy,
macrophages have also been implicated in eliciting a pain
response; depletion of macrophages after traumatic or
metabolic nerve injury significantly reduces or prevents the
progression of mechanical hyperalgesia and allodynia (21).
Macrophages are considered central players in the
pathophysiology of endometriosis, dictating both pro-
liferation and vascularization of lesions (22, 23). They are
observed clustered around nerve fibers in endometriosis
lesions (24), andwehavedemonstrateda functional 2-way
interaction between macrophages and nerves in endo-
metriosis that is mediated by E2 (25), a ligand that is gen-
erated in lesions by overexpression of steroidogenic
enzymes, including aromatase (26). Specifically, an E2-
dependent increase in chemokine ligand 2 (Ccl-2) bynerve
fibers recruits macrophages, which exhibit an increase in
expression of brain-derived neurotrophic factor (Bdnf)
and neurotrophin-3 (Nt-3), leading to concomitant neu-
rotrophic effects on nerves (25). Although macrophages
may promote nerve growth in endometriosis lesions, it is
not known if they contribute to endometriosis-associated
pain. Thus,we hypothesized thatmacrophages contribute
to endometriosis-associated pain by secreting factors that
encourage nerve growth and sensitization.
MATERIALS AND METHODS
Animals and reagents
C57BL/6 mice were purchased from Harlan (Indianapolis, IN,
USA). To achieve macrophage depletion, liposomal clodronate
(Encapsula NanoSciences, Brentwood, TN, USA) or saline (con-
trols)were injected intraperitoneally in 100ml volume. Liposomes
were administered every 48 h. Linsitinib, an IGF-1 receptor
(IGF-1R) inhibitor with modest activity of the insulin receptor
(40 mg/kg; Selleckchem, Houston, TX, USA), or vehicle (30%
polyethylene glycol 400, 0.5% Tween-80, and 5% propylene gly-
col) was administered by oral gavage every 24 h.Mice had access
to food andwater ad libitum. Ambient temperature and humidity
were 21°C and 50%, respectively.
Mouse model of endometriosis
Endometriosis was induced in mice as previously described by
Greaves et al. (13). In brief, donor mice were induced to undergo
endometrial breakdown in a menses-like event (27). Donor mice
were culled, and the endometrial tissuewas collected by opening
the decidualized uterine horn and scraping the endometrium
away from the underlying myometrium. Approximately 40 mg
of endometrial tissuewas injected into theperitoneal cavity of E2-
primed (500 ng E2 valerate) recipient mice. Experiment 1 (mac-
rophage depletion): 21 d post endometrial tissue injection, mice
with inducedendometriosis (n=31)were randomlyassigned to 1
of 2 groups: liposomal clodronate (n = 17) or saline (n = 14).
Behavior assessments were performed to ascertain pretreatment
recordings. Macrophage depletion was started on d 21 of the
endometriosis protocol and maintained for an additional
7 d (21–28 d). At 28 d, mice were culled, and the following
samples were recovered (see Fig. 1 for flow diagram accounting
for sample size for each endpoint): peritoneal lavage (n = 14 and
17; recoveredby injecting7ml ice-coldDMEMinto theperitoneal
cavity followed by gentle massage and recovery), peritoneal bi-
opsy (n = 10 each group), endometriosis lesions (n = 13 and 9),
lumbar spinal cord (T13-L5; n = 7), and medial prefrontal cortex
(brain;n= 7). Sampleswere also collected fromnaive (n=10) and
sham-treated (ovariectomy + E2 + intraperitoneal injection of
PBS; n = 9) animals. Samples were collected into RNAlater
(Thermo Fisher Scientific, Waltham, MA, USA) and frozen for
quantitative PCR (qPCR) analysis (peritoneum, spinal cord, and
brain), neutral-buffered formalin for paraffin embedding, and
immunohistochemical analysis (endometriosis lesions). Sus-
pected lesions were stained using hematoxylin and eosin and
assessed for the presence of stroma+/2 glands. Biopsies that did
not include either epithelial or stromal compartments were not
included in any further analysis. Experiment 2 (Igf-1r inhibition):
In a separate experiment, mice with induced endometriosis (n =
24) were randomly assigned to 1 of 2 groups (vehicle, n = 12 or
linsitinib, n = 12), and behavior assessments were performed.
Behavior assessments
Behavior assessments were performed as we have previously
described in detail (14). In this study, behavioral assessmentswere
performed in a blinded fashion, and all animals were acclima-
tized to the apparatus and handling prior to the initiation of be-
havior analysis. Spontaneous (grooming and activity) and evoked
(mechanical hyperalgesia measured using von Frey filaments)
behaviors were recorded. Experiment 1: Assessments were per-
formed on 31 mice with induced endometriosis (saline, n = 14;
liposomal, n = 17). Groups of naive (n = 10) and sham-treated
(ovariectomy+E2+ intraperitoneal injectionof PBS;n=9) animals
were included in all assessments. Experiment 2: Assessments
were performed on 24 mice with endometriosis (vehicle, n = 12;
linsitinib, n = 12), naive (n = 12), and sham-treated (n = 6) mice.
Patients and recovery of tissue and fluid samples
Endometriosis lesions (n = 8; proliferative phase, n = 4; and se-
cretoryphase,n=4) andperitoneal fluid (PF) (n=13;proliferative
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phase, n = 6; secretory phase, n = 7) were collected fromwomen
undergoing laparoscopic investigation for chronic pelvic pain
with presence of endometriosis confirmed at the time of surgery.
PFwas also collected fromwomen undergoing investigation for
chronic pelvic pain with the absence of endometriosis (n = 9;
proliferative phase, n = 5; secretory phase, n = 4). None of the
women had taken exogenous hormones for$3mo at the time of
sampling. Samples were collected, stored, and processed in ac-
cordance with Endometriosis Phenome and Biobanking Har-
monisation Project (EPHect) guidelines (28–31). Endometriosis
lesions were fixed in 4% neutral-buffered formalin and paraffin
embedded. PF samples were centrifuged to pellet any cells
and debris, divided into aliquots, and frozen at 280°. Pain
scores were calculated using the Endometriosis Health Profile 30
questionnaire.
In vitro generation of endometriosis-
associated macrophages
To isolate mononuclear leukocytes, blood was processed using
dextran sedimentation and separated on a Percoll (GE Health-
care, Waukesha, WI, USA) gradient with negative selection as
previously described by Greaves et al. (25). Adherent monocytes
were cultured on tissue culture plates in the presence of 4 ng/ml
M-CSF 1 for 7 d to generate monocyte-derived macrophages
(MDMs). Cells were cultured in DMEM (Thermo Fisher Scien-
tific) containing 10% AB human serum (AMS Biotechnology,
Milton,UnitedKingdom) in 12-well platesmaintained at 37°C in
5% CO2. After differentiation to macrophages, MDMs were ac-
tivated with PF from patients with (n = 7; secretory phase) or
without (n = 8; secretory phase) endometriosis diluted 1:1 in
medium for 24 h. Macrophages activated with PF from patients
with endometriosis are referred to as in vitro generated
endometriosis-associated macrophages (EAMs). We also in-
cluded prototypically polarized macrophages as controls; from
each blood preparation, somemacrophages were activated with
20 ng/ml IFN-g and 50 ng/ml LPS to generate proinflammatory
macrophages and others were activated with 20 ng/ml IL-4,
IL-10, and TGF-b to generate prorepair macrophages; unac-
tivated macrophages (M0s; medium only) were also included as
controls. Conditionedmediumwas collected by removing PF or
medium containing cytokines, washing once in fresh medium,
and then incubating in medium for an additional 24 h. The con-
ditionedmediumwascollectedandfrozen inaliquotsatOct4-80°C.
Human embryonic stem cell differentiation to
sensory neurons
Human embryonic stem cells (hESCs), strain H9 (WiCell, Madi-
son, WI, USA) were maintained and differentiated into sensory
neurons using small molecule inhibitors as previously described
in refs. 32 and 33. Differentiation was verified by confirming
down-regulation of the pluripotency marker octamer-binding
transcription factor 4 and up-regulation of the nociceptive genes
tachykinin precursor 1 (TAC1), sodium voltage-gated channel
(SCN) 9A, and SCN11A. Functionality of sensory neurons was
confirmed by stimulating cells with 4 nM capsaiscin (Milli-
poreSigma, Burlington, MA, USA) and recording intracellular
calcium flux using a calcium indicator kit (BD Biosciences, San
Jose, CA, USA), with calcium flux captured using a Novostar
microplate fluorometer (BMG Labtech, Cary, NC, USA).
Neuronal outgrowth assay
Embryonic rat dorsal root ganglia (DRGs) were isolated as pre-
viouslydescribed byGreaves et al. (34).Whole-ganglion explants
were plated onto poly-D-lysine- and Matrigel-coated wells (BD
Biosciences) in 48-well plates and incubated in DRG medium
(high-glucose DMEM supplemented with 0.01% penicillin-
streptomycin, 10% fetal calf serum). Positive controls were sup-
plemented with nerve growth factor (NGF) (Bio-Rad, Hercules,
CNS CNS
Figure 1. Flow diagram of mice
used for each experimental
endpoint. Control mice [n =
19; naive (n = 10); sham-treated
mice (n = 9)] and mice with
induced endometriosis [n = 31;
Endo (n = 14), Endo + Lipo
(n = 17)] were used for behav-
ior assessments and ﬂow cytom-
etry analysis of macrophage
populations. Of these, spinal
cord, brain, and peritoneal bi-
opsies were collected from n = 5
naive and n = 6 sham-treated
mice. Spinal cord and brain
were collected from n = 7, and
peritoneal biopsies were col-
lected from n = 10 Endo and
Endo + Lipo mice. CNS and
peritoneal tissue were subject to
gene expression analysis using
qPCR. We recovered lesions
from 13 (out of 14) Endo mice
and 9 (out of 17) Endo + Lipo
mice, and these were used for
immunoﬂuorescence. CNS, cen-
tral nervous system (spinal cord
and brain); Lipo, liposomes.
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CA, USA) plus recombinant IGF-1 (R&D Systems, Minneapolis,
MN,USA) (2–200 ng/ml)6 125–500 nMPicropodophyllin (PPP;
Tocris Bioscience, Bristol, United Kingdom). Some DRGs were
incubated in PF ormacrophage-conditionedmediumdiluted 1:1
in DRG medium 6 500 nM PPP. Images of explants were cap-
tured using an Axiovert microscope (Carl Zeiss, Oberkochen,
Germany), an Axiovision camera, and software.
Flow cytometry
Red blood cells were lysed from peritoneal lavages, and equal
numbersof cellswereblockedwith0.025mganti-CD16/32 (clone
93; BioLegend, San Diego, CA, USA) and then stained with a
combination of antibodies shown inTable 1. Fluorescenceminus
1 and negative controls were used to confirm gating strategies.
Just prior to analysis, DAPI and 123count eBeads allowing ab-
solute numbers of cells to be determined (Thermo Fisher Scien-
tific) were added to samples. Samples were acquired using an
LSRFortessa with FACSDiva software (BD Biosciences) and an-
alyzed with FlowJo v.9 software (FlowJo, Ashland, OR, USA).
Analysis was performed on single live cells determined using
forward scatter height vs. area and negativity for live or dead
(DAPI).
Real-time qPCR
RNA was extracted from human and mouse tissues by ho-
mogenization in Trizol reagent and chloroform phase sepa-
ration prior to processing using an RNAeasy Kit (Qiagen,
Hilden, Germany). RNA was extracted from cells using RLT
(lysis) buffer and an RNAeasy Kit. Concentration and purity
were assessed using a Nanodrop 1000 (Thermo Fisher Sci-
entific). A standard curve was generated by pooling un-
diluted RNA samples and performing four 10-fold dilutions.
cDNA was synthesized using SuperScript Vilo Enzyme
(Thermo Fisher Scientific) with 100 ng starting template in a
20-ml reaction. PCRs (10 ml) were performed using the Roche
Universal Library (Roche, Basel, Switzerland) and Express
qPCR Supermix (Thermo Fisher Scientific). cDNAwas added
at 1 ml per reaction, forward and reverse primers (Table 2)
were added at 20 mM, and thermal cycling conditions were
performed on a 7900 Fast real-time PCR machine (Thermo
Fisher Scientific) in 384-well plates with technical duplicates
performed. 18S (Thermo Fisher Scientific) was selected as the
reference gene. Data were analyzed using the relative stan-
dard curve method, and samples were normalized to 1 con-
sistent sample.
Immunofluorescence
Sections were antigen retrieved using citrate buffer, heat, and
pressure (pH 6.0 for CD68 or pH 9.0 for IGF-1) or trypsin tablets
dissolved in dH2O (for F4/80; MilliporeSigma) incubated with
sections for 20 min at 37°C. Sections were blocked for endoge-
nousperoxidase andnonspecific epitopes (species-specific serum
diluted 1:5 in Tris-buffered saline and 5%bovine serumalbumin)
and incubatedwithprimaryantibody (Table 3) at 4°Covernight.
Antibody detection was performed using a secondary pAb to
IgG(horseradishperoxidase) anda tyramidesignal amplification
system kit with cyanine (Cy) 3 or fluorescein (1:50 dilution; Per-
kinElmer, Waltham, MA, USA). For detection of the second an-
tigen in dual immunofluorescence, sectionswere boiled in citrate
buffer, and the second primary antibody was applied overnight
anddetected as before. Prior tomounting inPermafluor (Thermo
Fisher Scientific), sections were counterstained with DAPI. Im-
ages were captured using an LSM710 confocal microscope and
AxioCamcamera (CarlZeiss).Humanormouseuteruswasused
as a positive control tissue, andnegative controls hadomission of
the primary antibody.
IGF-1 ELISA
IGF-1 levels were detected in conditionedmedium and PF using
a Human IGF-1 DuoSet ELISA (R&D Systems) according to the
manufacturer’s instructions.
Statistics
Initially, data were tested for normality using Shapiro-Wilk and
Kolmogorov-Smirnov tests. Statistical analysis was performed
usingaStudent’s t test orMann-WhitneyU test (nonnormaldata)
to compare 2 experimental groups or a 1-way ANOVA with a
Tukey’s multiple comparison test to compare $3 experimental
groups. For von Frey data, medians were plotted, and a
Kruskal-Wallis test with a Dunn’s multiple comparison test was
performed.
Study approval
Mouse experiments were permitted under license by the United
Kingdom Home Office and were approved by the University of
Edinburgh Animal Welfare and Ethical Review Body (Edin-
burgh,UnitedKingdom). Behavior assessmentswereperformed
in accordancewith theGuidelines of the Committee forResearch
TABLE 1. Flow cytometry antibodies
Antibody Target cell Fluorochrome Supplier Dilution (v/v)
CD3 T cells APC BioLegend 1:100
B220 B cells APC BioLegend 1:100
NKp46 NK cells APC BioLegend 1:100
Siglec-F Eosinophils APC BD Biosciences 1:100
Cd11b Granulocytes BV650 BioLegend 1:100
CD45 Leukocytes PE/Dazzle594 BioLegend 1:1000
Ly6C Monocytes Paciﬁc Blue BioLegend 1:100
Ly6G Neutropils PE/Cy7 BioLegend 1:50
Cd11c Dendritic cells PERCP/Cy5.5 BioLegend 1:100
F4/80 Macrophages Alexa Fluor 488 BioLegend 1:50
DAPI 1:40,000
APC, allophycocyanin; BV650, Brilliant Violet 650; Ly6G, lymphocyte antigen 6 complex, locus G;
PE, phycoerythrin; PERCP, peridinin chlorophyll protein.
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and Ethical Issues of the International Association for the Study
of Pain. For the collection of patient biopsies, the study was ap-
proved by the Lothian Research Ethics Committee (LREC 11/
AL/0376), and all sampleswere collected after informed consent
was obtained in accordance with EPHect guidelines (29, 30).
Human venous blood was collected from healthy female vol-
unteers (n = 7) with informed consent and approval from the
Local Lothian Research Ethics Committee (AMREC 15-HV-013).
RESULTS
Macrophages play a key role in
endometriosis-associated hyperalgesia
in mice with induced endometriosis
In C57BL/6 mice with induced endometriosis, macro-
phages were depleted on d 21 post tissue injection using
liposomal clodronate. Injections were repeated every 48 h
(d 23, 25, and 27) tomaintain depletion, and themicewere
culled on d 28 (Fig. 2A). To confirm depletion of macro-
phages, we performed flow cytometry on cells isolated
from peritoneal lavage. Among CD45+, CD32, CD192,
NKp462, Siglec-F2, lymphocyte antigen 6 complex, locus
G2 (Ly6G), and Cd11b+ cells, 4 populations were sepa-
rated based on expression of F4/80 and lymphocyte an-
tigen 6 complex, locusC (Ly6C) (Fig. 2B). Thesewere large
peritoneal macrophages (LpMs; F4/80hi, Ly6C2), a pop-
ulation of F4/80hi Ly6C+ cells that likely represent a subset
of transient MDMs, and small peritoneal macrophages
(SpMs; F4/80lo, Ly6C2) and monocytes (F4/802, Ly6C+).
Administration of liposomal clodronate induced a signif-
icant depletion of LpMs (Fig. 2C; P, 0.001) and transient
MDMs (Fig. 2D; P , 0.05). There was no significant dif-
ference in numbers of SpMs (Fig. 2E). Lipsomal depletion
of macrophages in mice with endometriosis induced a
significant increase in the number ofmonocytes compared
with naive and sham-treatedmice (Fig. 2F), but monocyte
numbers were not significantly different to (nondepleted)
mice with endometriosis. We observed a significant in-
crease in the number of LpMs in mice with endometriosis
compared with naive animals (Fig. 2C; P , 0.01). We re-
covered lesions from13 (out of 14)mice treatedwith saline
and 9 (out of 17) mice treated with liposomal clodronate.
Using immunofluorescence, we identified a reduction in
F4/80+ macrophages present in endometriosis lesions
comparedwith control animals (Fig. 2G,H;P, 0.05).Mice
with endometriosis exhibited increased levels of sponta-
neous abdominal grooming (Fig. 2I; P , 0.01) and de-
creased levels of activity (Fig. 2J; P , 0.01) as well as
decreased abdominal retraction (Fig. 2K; P , 0.001) and
paw withdrawal thresholds (Fig. 2L; P , 0.001) when
stimulated with a punctate stimulus (von Frey filaments;
an evoked measure of mechanical hyperalgesia) com-
paredwith naive or sham-treated animals [consistentwith
what we have observed previously (14)]. Following mac-
rophage depletionwith liposomal clodronate, the levels of
grooming in the endometriosis mice declined such that
they were no longer different to those observed in naive
andsham-treatedanimals (Fig. 2I;P,0.05comparedwith
micewith induced endometriosis).Macrophage depletion
did not rescue activity levels in endometriosis mice (Fig.
2J). However, there was a significant difference in ab-
dominal retraction threshold between nondepleted and
macrophage-depleted endometriosis mice (Fig. 2K; P ,
0.001), with endometriosis mice withdrawing from a
lighter stimulus than depleted animals. Depletion of
macrophages also attenuated pawwithdrawal thresholds
in endometriosis mice (Fig. 2L; P , 0.05 compared with
TABLE 3. Primary antibodies used in immunoﬂuorescence
Antibody Host Species Supplier Dilution (v/v)
F4/80 Rat Mouse Thermo Fisher Scientiﬁc 1:600
CD68 Mouse Human Dako 1:800
IGF-1 Rabbit Human Santa Cruz Biotechnology 1:150
Neuroﬁlament Chicken Rat Covance 1:1000
TABLE 2. Primer sequences
Primer sequence, 59–39
Gene Forward Reverse UPL probe
Cox-2 GATGCTCTTCCGAGCTGTG GGATTGGAACAGCAAGGATTT 45
Tnf-a CTGTAGCCCACGTCGTAGC TTTGAGATCCATGCCGTTG 25
Igf-1 AGCAGCCTTCCAACTCAATTAT GAAGACGACATGATGTGTATCTTTATC 34
BDNF GTAACGGCGGCAGACAAA GACCTTTTCAAGGACTGTGACC 86
NT-3 CCCTTGTATCTCATGGAGGATT TTTCCGCCGTGATGTTCT 44
IGF-1 TGTGGAGACAGGGGCTTTTA ATCCACGATGCCTGTCTGA 67
SCN9A CAACTTTTAAGGGATGGACGA TCATATTTGGGCTGCTTGTCT 86
SCN11A ACCTGAGCCTGAACAACAGG TTTGAACTCTCTGGCTCGTG 2
TAC1 GCCTCAGCAGTTCTTTGGAT AGCCTTTAACAGGGCCACTT 89
Cox-2, cyclooxygenase-2; UPL, Universal Probe Library.
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Figure 2. Macrophages play a key role in endometriosis-associated hyperalgesia. A) Schematic of endometriosis model indicating
timing of behavioral tests and liposome–saline administration. B) Representative ﬂow plots showing peritoneal lavage of saline
control (left panel) and liposomal clodronate depleted (right panel). Myeloid cells were separated into 4 populations using F4/
80 and Ly6C; these were F4/80hi, Ly6C2 (LpMs), F4/80hi, Ly6C+ (MDMs), F4/80lo, Ly6Clo (SpMs), and Ly6C+, F4/802
(monocytes). C–F) Quantiﬁcation of ﬂow cytometry results normalized to 123count eBeads to allow resolution of absolute
numbers (naive mice, n = 10; sham-treated mice, n = 9; Endo, n = 14; Endo + Lipo, n = 17). C, D) Clodronate administration
caused depletion of LpMs (P , 0.001) (C) and MDMs (P , 0.05) (D). E) SpMs were not signiﬁcantly altered. F) Monocytes were
signiﬁcantly increased in depleted endometriosis mice compared with naive and sham-treated animals (P , 0.05). G)
Macrophages in the lesions of mice were visualized using F4/80 (red) immunoﬂuorescence. Scale bar, 50 mM. Inset on right
panel is negative control (negative primary antibody). H) Macrophage numbers [3 3 random ﬁelds of view (FOVs) per lesion
quantiﬁed] were reduced (P , 0.01) in the lesions of mice that received liposomal clodronate (n = 9 mice) compared with saline
(n = 13 mice). I) In C57BL/6 mice with endometriosis (n = 14), abdominally directed grooming was elevated compared with
naive (n = 10; P , 0.05) and sham-treated animals (n = 9; P , 0.01). Macrophage depletion (n = 17) decreased grooming levels
(P , 0.05). J ) Exploratory behavior was reduced in mice with endometriosis (P , 0.01). Macrophage depletion did not rescue
endometriosis-associated changes in activity. K) Macrophage depletion increased abdominal (P , 0.01) retraction thresholds. L)
Paw withdrawal thresholds were lower in endometriosis mice compared with naive and sham-treated animals (P , 0.001), and
macrophage depletion attenuated hind-paw withdrawal thresholds. A single time point (d 26) that exhibited maximal changes in
sensory behavior is shown. A Mann-Whitney U test, (H), 1-way ANOVA, and Tukey’s multiple comparison test (I, J ) or a Kruskal-
Wallis nonparametric test with Dunn’s multiple comparison test were performed (K, L). Lin, lineage; Lipo, liposome; OVX,
ovariectomy. *P , 0.05, **P , 0.01, ***P , 0.001.
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nondepleted endometriosis mice). Thus, it appears that
macrophagesplayakey role in altered sensorybehavior in
mice with endometriosis.
Depletion of macrophages attenuates
markers of inflammatory pain
hypersensitivity in the CNS of mice
with induced endometriosis
We have previously shown that the presence of endome-
triosis lesions leads to increased expression of nociceptive
and inflammatorymarkers (Trpv1, Scn11A, andCox-2) in
DRGs and spinal cords and the brains of mice with en-
dometriosis (14). Cox-2 has previously been implicated as
a marker of inflammatory pain hypersensitivity (35). In
line with our previous findings, endometriosis mice
exhibited increased mRNA expression of Cox-2 (Fig. 3A;
P, 0.01) as well as Tnf-a (Fig. 3B; P, 0.05) in the spinal
cord comparedwith naive and sham-treated animals, and
these levels were attenuated following macrophage de-
pletion using liposomal clodronate. Themedial prefrontal
cortices of the brains of mice with endometriosis also
exhibited apparent increased mRNA expression of in-
flammatory genes,withCox-2 being significantly different
to controls (Fig. 3C; P , 0.05). Expression of Cox-2 was
reversed bymacrophage depletion (P, 0.05).Tnf-a levels
in the brain were not significantly altered following mac-
rophage depletion (Fig. 3D). We conclude that detectable
molecular markers of inflammatory pain in the nervous
system of mice with endometriosis can be attenuated by
macrophage depletion.
Disease-modified macrophages in
endometriosis exhibit elevated
expression of IGF-1
To model EAMs in vitro, we activated human peripheral
blood MDMs (see Supplemental Fig. S1 for characteriza-
tion of monocyte-macrophage differentiation) collected
fromhealthy femalevolunteerswithPF frompatientswith
endometriosis (Fig. 4A). M0s, proinflammatory macro-
phages [M(LPS+IFN-g)], prorepairmacrophages [M(TGF-
b + IL-10 + IL-4)], and macrophages activated with PF
from women without endometriosis [M(No Endo)] were
included for comparison. In order to investigate factors
produced by macrophages that may contribute to pain in
endometriosis, we analyzed mRNA expression of key
neurotrophic genes. mRNA expression of BDNF was ele-
vated in EAMs compared with M(No Endo) (Fig. 4B; P,
0.05).ConcentrationsofNT-3also exhibit elevated levels in
EAMs but this data did not reach statistical significance
(Fig. 4C). mRNA concentrations of IGF-1 were signifi-
cantly elevated in EAMs (P , 0.001) compared with all
other macrophages, including macrophages activated
with PF from women without endometriosis [M(No
Endo); P , 0.05, Fig. 4D)]. We aimed to further validate
these data using patient biopsies. In endometriosis le-
sions recovered at surgery from women during the se-
cretory (progesterone-dominated) phase, we could detect
macrophages (CD68) that coexpressed IGF-1 using dual
immunofluorescence (Fig. 4E). We also confirmed ex-
pression of Igf-1 in F4/80+ macrophages in mouse endo-
metriosis lesions using immunofluorescence (Fig. 4F). In
support of these findings, we also demonstrated that Igf-1
mRNA concentrations were elevated in peritoneal bi-
opsies of mice with endometriosis, and levels were sig-
nificantly attenuated when macrophages were depleted
(Fig. 4G; P, 0.001).
IGF-1 is elevated in the PF of women
with endometriosis and correlates
with their pain scores
Weaimed to further explore the importanceof IGF-1 in the
mechanism behind endometriosis-associated pain in
women using human samples of PF. IGF-1 protein con-
centration was significantly elevated in the PF of women
with endometriosis compared with those without disease
(Fig. 5A;P, 0.05) regardless of cycle phase (Supplemental
Figure 3. Peripheral macrophages mediate endometriosis-
associated inﬂammation in the CNS. qPCR analysis revealed
evidence of apparent changes in the mRNA concentrations of
key inﬂammatory genes in the spinal (T13-L5 segments) and
medial prefrontal cortex area of the brains of mice with
endometriosis. A) In the spinal cords of mice with endome-
triosis (n = 7), Cox-2 mRNA was signiﬁcantly elevated (P ,
0.01) compared with naive (n = 5) and sham-treated (n = 6)
mice controls. This was attenuated following macrophage
depletion (n = 7; P , 0.01). B) Tnf-a mRNA concentrations
were increased in the spinal cords of mice with endometriosis
(P , 0.05), and macrophage depletion attenuated levels. C)
Cox-2 was also elevated in the brain (medial prefrontal cortex;
P , 0.05) of mice with endometriosis, and macrophage
depletion reduced expression (P , 0.05). D) Tnf-a was
increased but not signiﬁcantly in the brain, and macrophage
depletion reduced expression levels. Cox-2, cyclooxygenase-2;
Lipo, liposomes; RQ, relative quantiﬁcation.
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Fig. S2A).Wealso found that concentrations of IGF-1 in PF
positively correlated with patient-reported pain scores
(collected prior to surgery) in womenwith pelvic pain but
no endometriosis and women with endometriosis and
pelvic pain (Fig. 5B; P, 0.05). Thus, we hypothesized that
macrophage-derived IGF-1might be a key factor involved
in producing pain in endometriosis.
Macrophage-derived IGF-1 enhances
sprouting neurogenesis and nociceptive
gene expression in vitro
IGF-1 is a known neurotrophic and sensitizing factor
(36, 37). To determine potential mechanistic roles for
macrophage-derived IGF-1 in endometriosis-associated
pain,weexplored theeffectsofEAM-conditionedmedium
on neuronal cell cultures. Recombinant IGF-1 (200 ng)
stimulated sprouting neurogenesis in embryonic rat
whole DRG explants (P , 0.001); this was specifically
inhibited by 500 nM PPP (IGF-1R inhibitor; P, 0.05; Fig.
6A,B). PF fromwomenwith endometriosis (PF Endo) and
conditioned medium from EAMs also stimulated nerve
growth compared with PF from women without disease
(PFNo Endo; Fig. 6A, B; P, 0.01) or conditionedmedium
from macrophages activated with PF from women with-
out disease [M(No Endo); P , 0.001]. Sprouting neuro-
genesiswas inhibited following addition of 500 nMPPP in
each case (P, 0.05 and P, 0.01, respectively). Thus, the
neurotrophic effects of PF and macrophages in endome-
triosis are at least inpartmediatedby IGF-1.hESC-derived
sensory neurons (Fig. 6C) express ion channels that are
functionally active (32, 33). Incubation with EAM-
conditioned medium enhanced mRNA expression of the
nociceptive sodium voltage-gated ion channels SCN9A
(Fig. 6D;P, 0.01) andSCN11A(Fig. 6E;P, 0.001) but not
SCN3A, the vanilloid channel TRPV, or the purinergic
channel purinergic receptor P2X 3 (Supplemental Fig.
S3A–C). The neuropeptide Substance P (encoded by the
gene TAC1) was significantly up-regulated (Fig. 6F; P ,
0.001), but calcitonin gene-related peptide was not (Sup-
plemental Fig. S3D). Changes in gene expression were
attenuated by IGF-1R inhibition via PPP (P, 0.01). Thus,
we have shown a role for IGF-1 derived from EAMs in
contributing to nerve growth and sensitization in vitro.
Figure 4. Disease-modiﬁed mac-
rophages in endometriosis ex-
hibit elevated expression of
IGF-1. A) Schematic showing
generation of EAMs: peripheral
blood monocytes from healthy
female volunteers (n = 7) were
differentiated into macro-
phages for 7 d in the presence
of recombinant M-CSF 1. Mac-
rophages were then activated
for 24 h with PF from patients
with endometriosis (n = 7) or
without endometriosis (n = 8)
or activated with different cyto-
kines to generate inﬂammatory
(LPS + IFN-g) or repair (TGF-
b + IL-10 + IL-4; all n = 7)
macrophages and compared
with M0s. B–D) qPCR revealed
that EAMs had signiﬁcantly in-
creased mRNA concentration of
BDNF (P , 0.05) (B), elevated
levels of NT-3 (C), and signiﬁ-
cantly increased concentrations
of IGF-1 (P , 0.001) (D). E)
Dual immunoﬂuorescence for
CD68 (macrophages; red) and
IGF-1 (green) revealed that
macrophages in human endo-
metriosis lesions express IGF-1.
F) In lesions recovered from
mice with induced endometri-
osis, we identiﬁed F4/80+ mac-
rophages (red) that stained
positive for Igf-1 (green). Scale
bar, 50 mM. Top insets show
negative controls where the
primary antibody is omitted. G)
In peritoneal biopsies recovered
from endometriosis mice (n = 10), qPCR analysis revealed that mRNA concentration of Igf-1 was elevated (P, 0.05) compared with
naive (n = 5) and sham-treated (n = 6) animals. Macrophage depletion in endometriosis mice (n = 10) signiﬁcantly reduced Igf-1
expression (P , 0.001). RQ, relative quantiﬁcation. *P , 0.05, **P , 0.01, ***P , 0.001.
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Igf-1r inhibition attenuates hyperalgesia
in mice with induced endometriosis
To further explore the role of Igf-1 in mice with
endometriosis-associated pain, we inhibited Igf-1r using
linsitinib, a selective IGF-1R inhibitor that prevents auto-
phosphorylation and activation of downstream signaling.
Treatment of endometriosismicewith 40mg/kg linsitinib
decreased grooming levels in mice with endometriosis
(Fig. 7A; P, 0.05). Although activitywas reduced inmice
with endometriosis, treatment with linsitinib did not res-
cue this behavioral change (Fig. 7B). Abdominal retraction
(P, 0.01) andpawwithdrawal thresholds (P, 0.05)were
higher in endometriosis mice treated with linsitinib com-
paredwithvehicle-treatedmice (Fig. 7C,D) such that there
was no significant difference between linsitinib-treated
and control animals. These findings indicate that in-
hibition of Igf-1 signaling in mice with endometriosis can
attenuate endometriosis-associated-pain.
DISCUSSION
Endometriosis is a common incurable disease with dev-
astating impacts on health-related quality of life. Despite
its prevalence, there remains only limited treatment op-
tions, and new therapeutic strategies are an area of unmet
clinical need.Using a combinationof in vivo, ex-vivo, and in
vitro models, we show that macrophages play a key role
in endometriosis-associated hyperalgesia, that disease-
modified macrophages exhibit increased expression of
IGF-1, and that inhibition of macrophage-derived IGF-1
can attenuate nerve growth and expression of nociceptive
genes in vitro. Finally, we demonstrate that inhibition
of Igf-1r in mice with endometriosis can attenuate hyper-
algesia.Our study suggests thatmacrophages or signaling
resulting from factors that they produce such as IGF-1
could be targeted to alleviate endometriosis-associated
pain in women.
Pelvic pain is themost commonpresenting symptomof
endometriosis (38). The pain is thought to be a manifes-
tation of a 2-way dialogue between the nervous system
and endometriosis lesions: the presence of endometrial-
like tissue in the pelvic cavity of women with endometri-
osis causes inflammation (39), and lesions are innervated
by sensory nerve fibers that sense this peripheral in-
flammatory environment and generate a nociceptive re-
sponse resulting in pain perception. Macrophages are the
most abundant immune cell present within the pelvic
cavity (40), and inwomenwith endometriosis, an increase
in the number of macrophages both in the PF (41, 42)
and in lesions (43) is evident; thus, these cells may con-
tribute significantly to the inflammatory milieu present in
the disease. In our study, we used an established mouse
model of endometriosis to demonstrate that macro-
phage depletion using liposomal clodronate can attenu-
ate endometriosis-associated spontaneous grooming and
mechanical hyperalgesia (both locally and at a referred
site). This finding complements and extends studies car-
ried out in other rodent models of disease-related chronic
pain that report a role for macrophages andmonocytes in
the generation of pain-related behaviors (19221).
We have previously established that the presence of
endometriosis lesions inmice causesmolecular changes in
the CNS (14). In this study, we demonstrated that Cox-2
and Tnf-a were significantly elevated in the spinal cords
and brains of mice with endometriosis and that deple-
tion of peripheral macrophages attenuated expression of
these inflammatory markers. The expression of proin-
flammatory cytokinesandCox-2 in theCNSis abiomarker
of spinal neuroinflammation and centralized inflamma-
tory pain (12, 35, 44, 45). Our data suggest that macro-
phages present in the pelvic cavity and in endometriosis
lesionsplayakey role in establishingmaladaptive changes
in the CNS that are associated with enhanced pain per-
ception. It was surprising that these changes could be re-
versed, suggesting that inourmodel andat the time-points
analyzed, CNS alterations are dynamic. The extent of
spinal neuroinflammation in endometriosis remains un-
known, although recently it was shown that in a mini-
mally invasive model, mice with endometriosis exhibit
astrocyte activation and subtle changes in immunoreac-
tivity of microglia (46). Further characterizations of spinal
maladaptation’s characteristic of neuroinflammation in en-
dometriosis are warranted.
Macrophagesplaydiverse roles in health anddisease in
all tissues of the body and consequently exhibit tissue- and
disease-specific transcriptional profiles (47). In line with
this, peritoneal macrophages from women with endome-
triosis exhibit an enhanced activation state characterized
by enhanced expression of pro- and anti-inflammatory
cytokines (48). Studies in mice have demonstrated that
lesion-resident macrophages exhibit a phenotype that
promotes lesion growth and enhances vascularization of
lesions (22, 23), suggesting that EAMs exist as a disease-
modified population that exhibits a wound-healing phe-
notype. To investigate factors produced by macrophages
that may be implicated in contributing to endometriosis-
associated pain, we analyzed mRNA concentrations of
neurotrophins in in vitro generated EAMs. We identified
Figure 5. IGF-1 is elevated in the PF of women with endome-
triosis, and concentrations positively correlate with pain score.
A) ELISA analysis of PF from patients with endometriosis (n =
13; ENDO) revealed an increase (P , 0.05) in protein
concentrations of IGF-1 compared with patients without
endometriosis (n = 9; No Endo). B) We detected a positive
correlation between patient self-reported pain score [in
women with chronic pelvic pain and endometriosis (pink
dots) and chronic pelvic with no obvious pathology (blue
dots)] and IGF-1 protein concentrations. Statistical analysis was
performed using a Student’s t test or Pearson’s r test for
correlation. *P , 0.05.
MACROPHAGES IN ENDOMETRIOSIS-ASSOCIATED PAIN 9
Downloaded from www.fasebj.org by (137.205.202.131) on August 14, 2019. The FASEB Journal Vol. ${article.issue.getVolume()}, No. ${article.issue.getIssueNumber()}, primary_article.
that IGF-1 was significantly up-regulated in EAMs com-
pared with control macrophages. Of note, expression of
IGF-1 is a key characteristic of macrophages exhibiting a
tissue-repair or wound-healing phenotype (49). This sup-
ports the historical hypothesis that EAMs are prorepair
(23). We confirmed expression of Igf-1 in lesion-resident
macrophages in women with endometriosis and mice
with induced endometriosis, and we hypothesized that
macrophage-derived Igf-1 is likely to play a key role in the
pathogenesis of the disease.
PFconcentrationsof IGF-1havepreviouslybeen shown
to be elevated in patients with endometriosis compared
with those without (50), and we confirmed this in the
current study. IGF-1 present in the PF is thought to play
a role in the pathophysiology of endometriosis by
stimulating the growth of and preventing apoptosis of
endometrial-like cells (51). In endometriotic stromal cells,
IGF-1 up-regulates expression of estrogen receptor b and
aromatase, important drivers of endometriotic pathogen-
esis (52). Although these limited studies have inferred a
role for IGF-1 in thepathophysiologyof endometriosis, the
current study is the first to implicate a role for IGF-1 in
endometriosis-associated pain. In support of our findings,
we identified a positive correlation between PF IGF-1
concentrations and self-reported pain score in women
with chronic pain with and without endometriosis, al-
though there was no correlation with disease stage. There
is increasing evidence that Igf-1 contributes to pain hy-
persensitivity through binding to Igf-1r and activating
Igf-1r–mediated PI3K, ERK, protein kinase B, or MAPK
Figure 6. Macrophage-derived
IGF-1 enhances neuronal out-
growth and nociceptive gene
expression in vitro. A) Quantiﬁ-
cation of neuronal outgrowth
from rat DRG explants (be-
tween 18 and 40 explants per
group from embryos derived
from 5 pregnant dams). Out-
growth was maximal in the
presence of recombinant NGF
(positive control; P , 0.001
compared with negative con-
trol, which was DRG me-
dium in the absence of NGF).
Recombinant IGF-1 (200 ng)
also supported neuronal out-
growth (P , 0.05 compared
with negative control), and this
was abrogated by coincubation
with 500 nM PPP (speciﬁc IGF-
1R inhibitor; P, 0.05). PF from
patients with endometriosis (n =
7) signiﬁcantly enhanced neu-
ronal outgrowth compared with
PF from patients without endo-
metriosis (n = 8; P , 0.05). This
outgrowth was reduced follow-
ing addition of PPP. Condi-
tioned medium from in vitro
generated EAMs (n = 7) signif-
icantly enhanced neuronal out-
growth (P , 0.05) compared
with conditioned medium from
macrophages activated with PF
from patients without endome-
triosis [M(No Endo)]; this was
reduced following addition of
PPP. B) Representative images
of whole DRG explants follow-
ing incubation under different
conditions. +ve, DRG medium
with recombinant NGF; 2ve,
DRG medium without NGF;
CM, conditioned medium. Scale bar, 200 mM. C) Human sensory neurons were differentiated from H9 hESCs using small
molecular inhibitors as previously described by Chambers et al. (32). Axons are visualized using with neuroﬁlament (red), and
nuclei are stained with DAPI. D, E) qPCR analysis revealed that incubation of sensory neurons with EAM-conditioned medium
induced an increase in mRNA concentrations of SCN9A (encodes Nav1.7; P , 0.01) (D) and SCN11A (encodes Nav1.9; P ,
0.001) (E); this increase was abrogated following incubation with PPP (P , 0.01). F) mRNA concentrations of the neuropeptide
TAC1 (encodes substance P) were increased following incubation with EAM-conditioned medium (P , 0.001); this was reduced
with PPP. *P , 0.05, **P , 0.01, ***P , 0.001.
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intracellular signaling pathways (53). Igf-1r is widely
expressed in small, medium, and large DRG neurons (37,
54), and in chronic inflammatory and tissue injurymodels,
Igf-1 signaling enhances thermal and mechanical hyper-
algesia (54, 55). Moreover, inhibition of Igf-1r can reverse
mechanical allodynia and thermal hyperalgesia in a rat
model of cancer bone pain (36). In the current study,
Igf-1r inhibition had a profound effect on endometriosis-
associated hyperalgesia by reversing endometriosis-
associated spontaneous grooming as well as abdominal
and hind-paw hyperalgesia, thus validating a strong as-
sociation between IGF-1 signaling and endometriosis-
associated pain.
Finally, we were able to infer a strong link between
macrophage-derivedIGF-1andtheobservedendometriosis-
associated changes in sensory behavior usingmechanistic
in vitro models. We demonstrated that EAMs enhance
sprouting neurogenesis in rat DRG explants as well as
promote increased expression of nociceptive genes in hu-
man stemcell–derived sensoryneurons. IGF-1R inhibition
attenuates these observed changes. Critically, enhanced
expression of nociceptive genes is one of the first steps in
generating primary afferent sensitization (10). We there-
fore suggest that in endometriosis lesions macrophage-
derived IGF-1 contributes to pain by promoting nerve
growth in lesions and by sensitizing nerves by enhancing
nociceptive gene expression.
Global inhibition of IGF-1 or IGF-1R is likely to have
manyoff-target effectsdue to thepleiotropic rolesof IGF-1.
Thus, we suggest targeting disease-promoting macro-
phages as a potential future treatment for endometri-
osis. We now know that macrophages play a key role in
growth, vascularization, and innervationof endometriosis
lesions as well as generating endometriosis-associated
pain, placing these cells at the center of the pathophysiol-
ogy of a complex disorder. There are many pre- and early
clinical trials in cancer that are successfully testing im-
munotherapy, andkey areas to targetmacrophages are via
inhibition of recruitment, direct killing, or re-education of
disease-modified macrophages (56). However, before this
can be a possibility, it is vital for us to know more about
EAMs, their heterogeneity, and how they differ from
healthy macrophages required for normal physiologic
processes.
In summary, our study supports a previously un-
recognized critical role formacrophages in endometriosis-
associated hyperalgesia. The data suggest that
macrophage-derived IGF-1 is a key driver of hyperalgesia
in the disorder by promoting neurogenesis and nerve
sensitization. By targeting specific populations of macro-
phages that overexpress Igf-1, we may able to develop
innovative new treatments for the debilitating pain asso-
ciated with this common, incurable disease.
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